nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Prednisone—multiple sclerosis	0.288	1	CrCtD
Danazol—CCL2—multiple sclerosis	0.164	0.622	CbGaD
Danazol—PGR—multiple sclerosis	0.1	0.379	CbGaD
Danazol—PGR—Betamethasone—multiple sclerosis	0.0456	0.316	CbGbCtD
Danazol—PGR—Dexamethasone—multiple sclerosis	0.0265	0.184	CbGbCtD
Danazol—CYP19A1—Betamethasone—multiple sclerosis	0.0257	0.178	CbGbCtD
Danazol—CYP19A1—Dexamethasone—multiple sclerosis	0.0149	0.103	CbGbCtD
Danazol—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00948	0.0435	CrCrCtD
Danazol—Testolactone—Methylprednisolone—multiple sclerosis	0.00919	0.0422	CrCrCtD
Danazol—Testolactone—Betamethasone—multiple sclerosis	0.00905	0.0415	CrCrCtD
Danazol—Testolactone—Dexamethasone—multiple sclerosis	0.00905	0.0415	CrCrCtD
Danazol—Testolactone—Triamcinolone—multiple sclerosis	0.00884	0.0406	CrCrCtD
Danazol—Cortisone acetate—Prednisone—multiple sclerosis	0.00865	0.0397	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—multiple sclerosis	0.00844	0.0387	CrCrCtD
Danazol—Testolactone—Prednisone—multiple sclerosis	0.00839	0.0385	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00832	0.0382	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00832	0.0382	CrCrCtD
Danazol—Prednisone—Methylprednisolone—multiple sclerosis	0.00823	0.0378	CrCrCtD
Danazol—Testolactone—Prednisolone—multiple sclerosis	0.00819	0.0376	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00813	0.0373	CrCrCtD
Danazol—Prednisone—Betamethasone—multiple sclerosis	0.0081	0.0372	CrCrCtD
Danazol—Prednisone—Dexamethasone—multiple sclerosis	0.0081	0.0372	CrCrCtD
Danazol—Prednisone—Triamcinolone—multiple sclerosis	0.00792	0.0363	CrCrCtD
Danazol—CYP3A4—Fingolimod—multiple sclerosis	0.00776	0.0538	CbGbCtD
Danazol—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00753	0.0345	CrCrCtD
Danazol—Progesterone—Prednisolone—multiple sclerosis	0.00733	0.0337	CrCrCtD
Danazol—Prednisone—Prednisolone—multiple sclerosis	0.00733	0.0337	CrCrCtD
Danazol—Methyltestosterone—Prednisone—multiple sclerosis	0.00732	0.0336	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—multiple sclerosis	0.00715	0.0328	CrCrCtD
Danazol—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00671	0.0308	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00661	0.0303	CrCrCtD
Danazol—Hydrocortisone—Betamethasone—multiple sclerosis	0.00661	0.0303	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00646	0.0296	CrCrCtD
Danazol—Testosterone—Prednisolone—multiple sclerosis	0.00637	0.0292	CrCrCtD
Danazol—Hydrocortisone—Prednisone—multiple sclerosis	0.00613	0.0281	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—multiple sclerosis	0.00598	0.0274	CrCrCtD
Danazol—CYP3A4—Methylprednisolone—multiple sclerosis	0.005	0.0346	CbGbCtD
Danazol—CYP3A4—Triamcinolone—multiple sclerosis	0.00379	0.0263	CbGbCtD
Danazol—CYP3A4—Mitoxantrone—multiple sclerosis	0.00365	0.0253	CbGbCtD
Danazol—CYP3A4—Betamethasone—multiple sclerosis	0.00325	0.0225	CbGbCtD
Danazol—CYP3A4—Prednisolone—multiple sclerosis	0.00321	0.0222	CbGbCtD
Danazol—CYP3A4—Prednisone—multiple sclerosis	0.00303	0.021	CbGbCtD
Danazol—CYP3A4—Dexamethasone—multiple sclerosis	0.00189	0.0131	CbGbCtD
Danazol—GNRHR—brainstem—multiple sclerosis	0.000727	0.0917	CbGeAlD
Danazol—CCL2—retina—multiple sclerosis	0.000548	0.0691	CbGeAlD
Danazol—CCL2—medulla oblongata—multiple sclerosis	0.000396	0.0499	CbGeAlD
Danazol—GNRHR—nervous system—multiple sclerosis	0.000381	0.0481	CbGeAlD
Danazol—GNRHR—central nervous system—multiple sclerosis	0.000367	0.0463	CbGeAlD
Danazol—CCL2—midbrain—multiple sclerosis	0.000362	0.0456	CbGeAlD
Danazol—GNRHR—cerebellum—multiple sclerosis	0.000359	0.0452	CbGeAlD
Danazol—CCL2—spinal cord—multiple sclerosis	0.000353	0.0445	CbGeAlD
Danazol—SHBG—brainstem—multiple sclerosis	0.000331	0.0418	CbGeAlD
Danazol—Norelgestromin—PGR—multiple sclerosis	0.000306	0.225	CrCbGaD
Danazol—CCL2—nervous system—multiple sclerosis	0.000298	0.0375	CbGeAlD
Danazol—Desogestrel—PGR—multiple sclerosis	0.000294	0.217	CrCbGaD
Danazol—GNRHR—brain—multiple sclerosis	0.000291	0.0367	CbGeAlD
Danazol—CCL2—central nervous system—multiple sclerosis	0.000286	0.0361	CbGeAlD
Danazol—CCL2—cerebellum—multiple sclerosis	0.00028	0.0353	CbGeAlD
Danazol—Etonogestrel—PGR—multiple sclerosis	0.000238	0.175	CrCbGaD
Danazol—ESR1—brainstem—multiple sclerosis	0.000233	0.0294	CbGeAlD
Danazol—CCL2—brain—multiple sclerosis	0.000227	0.0287	CbGeAlD
Danazol—Levonorgestrel—PGR—multiple sclerosis	0.000168	0.124	CrCbGaD
Danazol—SHBG—central nervous system—multiple sclerosis	0.000167	0.0211	CbGeAlD
Danazol—SHBG—cerebellum—multiple sclerosis	0.000163	0.0206	CbGeAlD
Danazol—PGR—nervous system—multiple sclerosis	0.000156	0.0197	CbGeAlD
Danazol—PGR—central nervous system—multiple sclerosis	0.000151	0.019	CbGeAlD
Danazol—AR—spinal cord—multiple sclerosis	0.000148	0.0186	CbGeAlD
Danazol—PGR—cerebellum—multiple sclerosis	0.000147	0.0186	CbGeAlD
Danazol—CYP19A1—nervous system—multiple sclerosis	0.000141	0.0177	CbGeAlD
Danazol—Norethindrone—PGR—multiple sclerosis	0.000137	0.101	CrCbGaD
Danazol—CYP19A1—central nervous system—multiple sclerosis	0.000135	0.0171	CbGeAlD
Danazol—SHBG—brain—multiple sclerosis	0.000133	0.0167	CbGeAlD
Danazol—AR—nervous system—multiple sclerosis	0.000125	0.0157	CbGeAlD
Danazol—ESR1—nervous system—multiple sclerosis	0.000122	0.0154	CbGeAlD
Danazol—AR—central nervous system—multiple sclerosis	0.00012	0.0151	CbGeAlD
Danazol—PGR—brain—multiple sclerosis	0.00012	0.0151	CbGeAlD
Danazol—ESR1—central nervous system—multiple sclerosis	0.000118	0.0148	CbGeAlD
Danazol—ESR1—cerebellum—multiple sclerosis	0.000115	0.0145	CbGeAlD
Danazol—CYP19A1—brain—multiple sclerosis	0.000108	0.0136	CbGeAlD
Danazol—AR—brain—multiple sclerosis	9.52e-05	0.012	CbGeAlD
Danazol—ESR1—brain—multiple sclerosis	9.35e-05	0.0118	CbGeAlD
Danazol—Progesterone—PGR—multiple sclerosis	7.95e-05	0.0586	CrCbGaD
Danazol—Haemorrhage—Prednisolone—multiple sclerosis	7.7e-05	0.00193	CcSEcCtD
Danazol—Vision blurred—Mitoxantrone—multiple sclerosis	7.7e-05	0.00193	CcSEcCtD
Danazol—Photosensitivity—Methotrexate—multiple sclerosis	7.7e-05	0.00193	CcSEcCtD
Danazol—Mood swings—Prednisone—multiple sclerosis	7.66e-05	0.00192	CcSEcCtD
Danazol—Sweating—Methylprednisolone—multiple sclerosis	7.55e-05	0.00189	CcSEcCtD
Danazol—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	7.52e-05	0.00188	CcSEcCtD
Danazol—Visual impairment—Prednisolone—multiple sclerosis	7.42e-05	0.00186	CcSEcCtD
Danazol—Leukopenia—Mitoxantrone—multiple sclerosis	7.32e-05	0.00183	CcSEcCtD
Danazol—Weight increased—Betamethasone—multiple sclerosis	7.31e-05	0.00183	CcSEcCtD
Danazol—Weight increased—Dexamethasone—multiple sclerosis	7.31e-05	0.00183	CcSEcCtD
Danazol—Asthenia—Cladribine—multiple sclerosis	7.28e-05	0.00182	CcSEcCtD
Danazol—Pruritus—Cladribine—multiple sclerosis	7.18e-05	0.0018	CcSEcCtD
Danazol—Visual disturbance—Methotrexate—multiple sclerosis	7.13e-05	0.00178	CcSEcCtD
Danazol—Haemoglobin—Triamcinolone—multiple sclerosis	7.12e-05	0.00178	CcSEcCtD
Danazol—Haemoglobin—Methylprednisolone—multiple sclerosis	7.1e-05	0.00178	CcSEcCtD
Danazol—Haemorrhage—Triamcinolone—multiple sclerosis	7.08e-05	0.00177	CcSEcCtD
Danazol—Convulsion—Mitoxantrone—multiple sclerosis	7.08e-05	0.00177	CcSEcCtD
Danazol—Haemorrhage—Methylprednisolone—multiple sclerosis	7.07e-05	0.00177	CcSEcCtD
Danazol—Acute coronary syndrome—Betamethasone—multiple sclerosis	7.06e-05	0.00176	CcSEcCtD
Danazol—Acute coronary syndrome—Dexamethasone—multiple sclerosis	7.06e-05	0.00176	CcSEcCtD
Danazol—Hypertension—Mitoxantrone—multiple sclerosis	7.06e-05	0.00176	CcSEcCtD
Danazol—Myocardial infarction—Dexamethasone—multiple sclerosis	7.02e-05	0.00175	CcSEcCtD
Danazol—Myocardial infarction—Betamethasone—multiple sclerosis	7.02e-05	0.00175	CcSEcCtD
Danazol—Arthralgia—Mitoxantrone—multiple sclerosis	6.96e-05	0.00174	CcSEcCtD
Danazol—Anxiety—Mitoxantrone—multiple sclerosis	6.93e-05	0.00173	CcSEcCtD
Danazol—Pancreatitis—Prednisone—multiple sclerosis	6.86e-05	0.00171	CcSEcCtD
Danazol—CYP3A4—nervous system—multiple sclerosis	6.82e-05	0.0086	CbGeAlD
Danazol—Visual impairment—Methylprednisolone—multiple sclerosis	6.81e-05	0.0017	CcSEcCtD
Danazol—Dizziness—Cladribine—multiple sclerosis	6.71e-05	0.00168	CcSEcCtD
Danazol—Oedema—Mitoxantrone—multiple sclerosis	6.67e-05	0.00167	CcSEcCtD
Danazol—CYP3A4—central nervous system—multiple sclerosis	6.57e-05	0.00828	CbGeAlD
Danazol—Shock—Mitoxantrone—multiple sclerosis	6.56e-05	0.00164	CcSEcCtD
Danazol—Thrombocytopenia—Mitoxantrone—multiple sclerosis	6.53e-05	0.00163	CcSEcCtD
Danazol—Body temperature increased—Azathioprine—multiple sclerosis	6.52e-05	0.00163	CcSEcCtD
Danazol—Tachycardia—Mitoxantrone—multiple sclerosis	6.51e-05	0.00163	CcSEcCtD
Danazol—Haemoglobin—Dexamethasone—multiple sclerosis	6.46e-05	0.00162	CcSEcCtD
Danazol—Haemoglobin—Betamethasone—multiple sclerosis	6.46e-05	0.00162	CcSEcCtD
Danazol—Irritability—Methotrexate—multiple sclerosis	6.45e-05	0.00161	CcSEcCtD
Danazol—Vomiting—Cladribine—multiple sclerosis	6.45e-05	0.00161	CcSEcCtD
Danazol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	6.45e-05	0.00161	CcSEcCtD
Danazol—Haemorrhage—Betamethasone—multiple sclerosis	6.43e-05	0.00161	CcSEcCtD
Danazol—Haemorrhage—Dexamethasone—multiple sclerosis	6.43e-05	0.00161	CcSEcCtD
Danazol—Mood swings—Methotrexate—multiple sclerosis	6.41e-05	0.0016	CcSEcCtD
Danazol—Rash—Cladribine—multiple sclerosis	6.4e-05	0.0016	CcSEcCtD
Danazol—Dermatitis—Cladribine—multiple sclerosis	6.39e-05	0.0016	CcSEcCtD
Danazol—Weight increased—Prednisone—multiple sclerosis	6.36e-05	0.00159	CcSEcCtD
Danazol—Headache—Cladribine—multiple sclerosis	6.36e-05	0.00159	CcSEcCtD
Danazol—Vision blurred—Prednisolone—multiple sclerosis	6.32e-05	0.00158	CcSEcCtD
Danazol—Visual impairment—Betamethasone—multiple sclerosis	6.19e-05	0.00155	CcSEcCtD
Danazol—Visual impairment—Dexamethasone—multiple sclerosis	6.19e-05	0.00155	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisone—multiple sclerosis	6.15e-05	0.00154	CcSEcCtD
Danazol—Myocardial infarction—Prednisone—multiple sclerosis	6.11e-05	0.00153	CcSEcCtD
Danazol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	6.08e-05	0.00152	CcSEcCtD
Danazol—Nausea—Cladribine—multiple sclerosis	6.03e-05	0.00151	CcSEcCtD
Danazol—Vertigo—Prednisolone—multiple sclerosis	6.02e-05	0.00151	CcSEcCtD
Danazol—Syncope—Prednisolone—multiple sclerosis	6.01e-05	0.0015	CcSEcCtD
Danazol—Paraesthesia—Mitoxantrone—multiple sclerosis	5.99e-05	0.0015	CcSEcCtD
Danazol—Back pain—Triamcinolone—multiple sclerosis	5.96e-05	0.00149	CcSEcCtD
Danazol—Loss of consciousness—Prednisolone—multiple sclerosis	5.89e-05	0.00147	CcSEcCtD
Danazol—Dyspepsia—Mitoxantrone—multiple sclerosis	5.87e-05	0.00147	CcSEcCtD
Danazol—Convulsion—Prednisolone—multiple sclerosis	5.81e-05	0.00145	CcSEcCtD
Danazol—Hypertension—Prednisolone—multiple sclerosis	5.79e-05	0.00145	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—multiple sclerosis	5.79e-05	0.00145	CcSEcCtD
Danazol—Fatigue—Mitoxantrone—multiple sclerosis	5.75e-05	0.00144	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—multiple sclerosis	5.73e-05	0.00143	CcSEcCtD
Danazol—Constipation—Mitoxantrone—multiple sclerosis	5.7e-05	0.00143	CcSEcCtD
Danazol—Alopecia—Dexamethasone—multiple sclerosis	5.68e-05	0.00142	CcSEcCtD
Danazol—Alopecia—Betamethasone—multiple sclerosis	5.68e-05	0.00142	CcSEcCtD
Danazol—Haemoglobin—Prednisone—multiple sclerosis	5.63e-05	0.00141	CcSEcCtD
Danazol—Haemorrhage—Prednisone—multiple sclerosis	5.6e-05	0.0014	CcSEcCtD
Danazol—Vertigo—Triamcinolone—multiple sclerosis	5.54e-05	0.00139	CcSEcCtD
Danazol—Syncope—Triamcinolone—multiple sclerosis	5.53e-05	0.00138	CcSEcCtD
Danazol—Vertigo—Methylprednisolone—multiple sclerosis	5.53e-05	0.00138	CcSEcCtD
Danazol—Syncope—Methylprednisolone—multiple sclerosis	5.52e-05	0.00138	CcSEcCtD
Danazol—Oedema—Prednisolone—multiple sclerosis	5.47e-05	0.00137	CcSEcCtD
Danazol—Dizziness—Azathioprine—multiple sclerosis	5.46e-05	0.00136	CcSEcCtD
Danazol—Loss of consciousness—Triamcinolone—multiple sclerosis	5.42e-05	0.00136	CcSEcCtD
Danazol—Loss of consciousness—Methylprednisolone—multiple sclerosis	5.41e-05	0.00135	CcSEcCtD
Danazol—Shock—Prednisolone—multiple sclerosis	5.38e-05	0.00135	CcSEcCtD
Danazol—Convulsion—Triamcinolone—multiple sclerosis	5.34e-05	0.00134	CcSEcCtD
Danazol—Tachycardia—Prednisolone—multiple sclerosis	5.34e-05	0.00134	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—multiple sclerosis	5.33e-05	0.00133	CcSEcCtD
Danazol—Convulsion—Methylprednisolone—multiple sclerosis	5.33e-05	0.00133	CcSEcCtD
Danazol—Hypertension—Triamcinolone—multiple sclerosis	5.32e-05	0.00133	CcSEcCtD
Danazol—Hypertension—Methylprednisolone—multiple sclerosis	5.31e-05	0.00133	CcSEcCtD
Danazol—Urticaria—Mitoxantrone—multiple sclerosis	5.3e-05	0.00132	CcSEcCtD
Danazol—Hyperhidrosis—Prednisolone—multiple sclerosis	5.29e-05	0.00132	CcSEcCtD
Danazol—Body temperature increased—Mitoxantrone—multiple sclerosis	5.27e-05	0.00132	CcSEcCtD
Danazol—Vomiting—Azathioprine—multiple sclerosis	5.25e-05	0.00131	CcSEcCtD
Danazol—Arthralgia—Methylprednisolone—multiple sclerosis	5.24e-05	0.00131	CcSEcCtD
Danazol—Anxiety—Methylprednisolone—multiple sclerosis	5.22e-05	0.00131	CcSEcCtD
Danazol—Rash—Azathioprine—multiple sclerosis	5.2e-05	0.0013	CcSEcCtD
Danazol—Dermatitis—Azathioprine—multiple sclerosis	5.2e-05	0.0013	CcSEcCtD
Danazol—Flushing—Prednisone—multiple sclerosis	5.19e-05	0.0013	CcSEcCtD
Danazol—Headache—Azathioprine—multiple sclerosis	5.17e-05	0.00129	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	5.17e-05	0.00129	CcSEcCtD
Danazol—Oedema—Triamcinolone—multiple sclerosis	5.03e-05	0.00126	CcSEcCtD
Danazol—Vertigo—Dexamethasone—multiple sclerosis	5.03e-05	0.00126	CcSEcCtD
Danazol—Vertigo—Betamethasone—multiple sclerosis	5.03e-05	0.00126	CcSEcCtD
Danazol—Syncope—Dexamethasone—multiple sclerosis	5.02e-05	0.00125	CcSEcCtD
Danazol—Syncope—Betamethasone—multiple sclerosis	5.02e-05	0.00125	CcSEcCtD
Danazol—Sweating—Methotrexate—multiple sclerosis	5e-05	0.00125	CcSEcCtD
Danazol—Haematuria—Methotrexate—multiple sclerosis	4.97e-05	0.00124	CcSEcCtD
Danazol—Shock—Triamcinolone—multiple sclerosis	4.95e-05	0.00124	CcSEcCtD
Danazol—Alopecia—Prednisone—multiple sclerosis	4.95e-05	0.00124	CcSEcCtD
Danazol—Shock—Methylprednisolone—multiple sclerosis	4.94e-05	0.00124	CcSEcCtD
Danazol—Loss of consciousness—Betamethasone—multiple sclerosis	4.92e-05	0.00123	CcSEcCtD
Danazol—Loss of consciousness—Dexamethasone—multiple sclerosis	4.92e-05	0.00123	CcSEcCtD
Danazol—Paraesthesia—Prednisolone—multiple sclerosis	4.91e-05	0.00123	CcSEcCtD
Danazol—Tachycardia—Triamcinolone—multiple sclerosis	4.91e-05	0.00123	CcSEcCtD
Danazol—Nausea—Azathioprine—multiple sclerosis	4.9e-05	0.00123	CcSEcCtD
Danazol—Tachycardia—Methylprednisolone—multiple sclerosis	4.9e-05	0.00123	CcSEcCtD
Danazol—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.86e-05	0.00122	CcSEcCtD
Danazol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.85e-05	0.00121	CcSEcCtD
Danazol—Convulsion—Dexamethasone—multiple sclerosis	4.85e-05	0.00121	CcSEcCtD
Danazol—Convulsion—Betamethasone—multiple sclerosis	4.85e-05	0.00121	CcSEcCtD
Danazol—Hypertension—Dexamethasone—multiple sclerosis	4.83e-05	0.00121	CcSEcCtD
Danazol—Hypertension—Betamethasone—multiple sclerosis	4.83e-05	0.00121	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Betamethasone—multiple sclerosis	4.79e-05	0.0236	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—multiple sclerosis	4.79e-05	0.0236	CbGdCrCtD
Danazol—Asthenia—Mitoxantrone—multiple sclerosis	4.79e-05	0.0012	CcSEcCtD
Danazol—Anxiety—Dexamethasone—multiple sclerosis	4.75e-05	0.00119	CcSEcCtD
Danazol—Anxiety—Betamethasone—multiple sclerosis	4.75e-05	0.00119	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—multiple sclerosis	4.7e-05	0.00118	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Triamcinolone—multiple sclerosis	4.68e-05	0.023	CbGdCrCtD
Danazol—Haemorrhage—Methotrexate—multiple sclerosis	4.68e-05	0.00117	CcSEcCtD
Danazol—Vision blurred—Prednisone—multiple sclerosis	4.59e-05	0.00115	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.58e-05	0.00115	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.57e-05	0.00114	CcSEcCtD
Danazol—Oedema—Dexamethasone—multiple sclerosis	4.57e-05	0.00114	CcSEcCtD
Danazol—Oedema—Betamethasone—multiple sclerosis	4.57e-05	0.00114	CcSEcCtD
Danazol—Paraesthesia—Triamcinolone—multiple sclerosis	4.52e-05	0.00113	CcSEcCtD
Danazol—Paraesthesia—Methylprednisolone—multiple sclerosis	4.51e-05	0.00113	CcSEcCtD
Danazol—Visual impairment—Methotrexate—multiple sclerosis	4.51e-05	0.00113	CcSEcCtD
Danazol—Shock—Dexamethasone—multiple sclerosis	4.49e-05	0.00112	CcSEcCtD
Danazol—Shock—Betamethasone—multiple sclerosis	4.49e-05	0.00112	CcSEcCtD
Danazol—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.47e-05	0.00112	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—multiple sclerosis	4.47e-05	0.00112	CcSEcCtD
Danazol—Tachycardia—Dexamethasone—multiple sclerosis	4.46e-05	0.00111	CcSEcCtD
Danazol—Tachycardia—Betamethasone—multiple sclerosis	4.46e-05	0.00111	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisone—multiple sclerosis	4.44e-05	0.0219	CbGdCrCtD
Danazol—Dyspepsia—Triamcinolone—multiple sclerosis	4.43e-05	0.00111	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—multiple sclerosis	4.42e-05	0.00111	CcSEcCtD
Danazol—Dyspepsia—Methylprednisolone—multiple sclerosis	4.42e-05	0.00111	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—multiple sclerosis	4.41e-05	0.0011	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—multiple sclerosis	4.41e-05	0.0011	CcSEcCtD
Danazol—Vertigo—Prednisone—multiple sclerosis	4.38e-05	0.00109	CcSEcCtD
Danazol—Syncope—Prednisone—multiple sclerosis	4.37e-05	0.00109	CcSEcCtD
Danazol—Urticaria—Prednisolone—multiple sclerosis	4.35e-05	0.00109	CcSEcCtD
Danazol—Fatigue—Triamcinolone—multiple sclerosis	4.34e-05	0.00108	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—multiple sclerosis	4.34e-05	0.0213	CbGdCrCtD
Danazol—Fatigue—Methylprednisolone—multiple sclerosis	4.33e-05	0.00108	CcSEcCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—multiple sclerosis	4.3e-05	0.0211	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Betamethasone—multiple sclerosis	4.3e-05	0.0211	CbGdCrCtD
Danazol—Loss of consciousness—Prednisone—multiple sclerosis	4.28e-05	0.00107	CcSEcCtD
Danazol—Vomiting—Mitoxantrone—multiple sclerosis	4.24e-05	0.00106	CcSEcCtD
Danazol—Convulsion—Prednisone—multiple sclerosis	4.22e-05	0.00106	CcSEcCtD
Danazol—Hypertension—Prednisone—multiple sclerosis	4.21e-05	0.00105	CcSEcCtD
Danazol—Rash—Mitoxantrone—multiple sclerosis	4.21e-05	0.00105	CcSEcCtD
Danazol—Dermatitis—Mitoxantrone—multiple sclerosis	4.2e-05	0.00105	CcSEcCtD
Danazol—CCL2—Beclomethasone—Triamcinolone—multiple sclerosis	4.2e-05	0.0207	CbGdCrCtD
Danazol—Chills—Methotrexate—multiple sclerosis	4.2e-05	0.00105	CcSEcCtD
Danazol—Headache—Mitoxantrone—multiple sclerosis	4.18e-05	0.00104	CcSEcCtD
Danazol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.16e-05	0.00104	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.16e-05	0.00104	CcSEcCtD
Danazol—Arthralgia—Prednisone—multiple sclerosis	4.15e-05	0.00104	CcSEcCtD
Danazol—Anxiety—Prednisone—multiple sclerosis	4.13e-05	0.00103	CcSEcCtD
Danazol—Alopecia—Methotrexate—multiple sclerosis	4.13e-05	0.00103	CcSEcCtD
Danazol—Paraesthesia—Betamethasone—multiple sclerosis	4.1e-05	0.00103	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—multiple sclerosis	4.1e-05	0.00103	CcSEcCtD
Danazol—CCL2—Fluocinonide—Methylprednisolone—multiple sclerosis	4.03e-05	0.0198	CbGdCrCtD
Danazol—Dyspepsia—Betamethasone—multiple sclerosis	4.02e-05	0.00101	CcSEcCtD
Danazol—Dyspepsia—Dexamethasone—multiple sclerosis	4.02e-05	0.00101	CcSEcCtD
Danazol—Urticaria—Triamcinolone—multiple sclerosis	4e-05	0.001	CcSEcCtD
Danazol—Urticaria—Methylprednisolone—multiple sclerosis	3.99e-05	0.000997	CcSEcCtD
Danazol—Body temperature increased—Triamcinolone—multiple sclerosis	3.98e-05	0.000995	CcSEcCtD
Danazol—Oedema—Prednisone—multiple sclerosis	3.98e-05	0.000994	CcSEcCtD
Danazol—CCL2—Fluocinonide—Betamethasone—multiple sclerosis	3.97e-05	0.0195	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Dexamethasone—multiple sclerosis	3.97e-05	0.0195	CbGdCrCtD
Danazol—Nausea—Mitoxantrone—multiple sclerosis	3.96e-05	0.000991	CcSEcCtD
Danazol—Back pain—Methotrexate—multiple sclerosis	3.94e-05	0.000985	CcSEcCtD
Danazol—Fatigue—Dexamethasone—multiple sclerosis	3.94e-05	0.000984	CcSEcCtD
Danazol—Fatigue—Betamethasone—multiple sclerosis	3.94e-05	0.000984	CcSEcCtD
Danazol—Shock—Prednisone—multiple sclerosis	3.91e-05	0.000978	CcSEcCtD
Danazol—Prednisone—ALB—multiple sclerosis	3.89e-05	0.0287	CrCbGaD
Danazol—CCL2—Beclomethasone—Prednisolone—multiple sclerosis	3.89e-05	0.0191	CbGdCrCtD
Danazol—Tachycardia—Prednisone—multiple sclerosis	3.88e-05	0.00097	CcSEcCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—multiple sclerosis	3.88e-05	0.0191	CbGdCrCtD
Danazol—Hyperhidrosis—Prednisone—multiple sclerosis	3.84e-05	0.000961	CcSEcCtD
Danazol—Vision blurred—Methotrexate—multiple sclerosis	3.84e-05	0.00096	CcSEcCtD
Danazol—Norethindrone—ALB—multiple sclerosis	3.84e-05	0.0283	CrCbGaD
Danazol—CCL2—Amcinonide—Dexamethasone—multiple sclerosis	3.8e-05	0.0187	CbGdCrCtD
Danazol—CCL2—Amcinonide—Betamethasone—multiple sclerosis	3.8e-05	0.0187	CbGdCrCtD
Danazol—CCL2—Amcinonide—Triamcinolone—multiple sclerosis	3.72e-05	0.0183	CbGdCrCtD
Danazol—Vertigo—Methotrexate—multiple sclerosis	3.66e-05	0.000915	CcSEcCtD
Danazol—Leukopenia—Methotrexate—multiple sclerosis	3.64e-05	0.000911	CcSEcCtD
Danazol—Methyltestosterone—ALB—multiple sclerosis	3.64e-05	0.0268	CrCbGaD
Danazol—Urticaria—Betamethasone—multiple sclerosis	3.63e-05	0.000907	CcSEcCtD
Danazol—Urticaria—Dexamethasone—multiple sclerosis	3.63e-05	0.000907	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.62e-05	0.000906	CcSEcCtD
Danazol—Dizziness—Prednisolone—multiple sclerosis	3.62e-05	0.000905	CcSEcCtD
Danazol—Asthenia—Triamcinolone—multiple sclerosis	3.61e-05	0.000903	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—multiple sclerosis	3.61e-05	0.000903	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—multiple sclerosis	3.61e-05	0.000903	CcSEcCtD
Danazol—Asthenia—Methylprednisolone—multiple sclerosis	3.6e-05	0.000901	CcSEcCtD
Danazol—Paraesthesia—Prednisone—multiple sclerosis	3.57e-05	0.000893	CcSEcCtD
Danazol—Pruritus—Triamcinolone—multiple sclerosis	3.56e-05	0.00089	CcSEcCtD
Danazol—Pruritus—Methylprednisolone—multiple sclerosis	3.55e-05	0.000888	CcSEcCtD
Danazol—Convulsion—Methotrexate—multiple sclerosis	3.53e-05	0.000882	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisone—multiple sclerosis	3.53e-05	0.0173	CbGdCrCtD
Danazol—Dyspepsia—Prednisone—multiple sclerosis	3.5e-05	0.000875	CcSEcCtD
Danazol—Arthralgia—Methotrexate—multiple sclerosis	3.47e-05	0.000867	CcSEcCtD
Danazol—Rash—Prednisolone—multiple sclerosis	3.45e-05	0.000863	CcSEcCtD
Danazol—Dermatitis—Prednisolone—multiple sclerosis	3.45e-05	0.000862	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisolone—multiple sclerosis	3.44e-05	0.0169	CbGdCrCtD
Danazol—Fatigue—Prednisone—multiple sclerosis	3.43e-05	0.000857	CcSEcCtD
Danazol—Headache—Prednisolone—multiple sclerosis	3.43e-05	0.000857	CcSEcCtD
Danazol—Constipation—Prednisone—multiple sclerosis	3.4e-05	0.00085	CcSEcCtD
Danazol—Dizziness—Triamcinolone—multiple sclerosis	3.33e-05	0.000832	CcSEcCtD
Danazol—Dizziness—Methylprednisolone—multiple sclerosis	3.32e-05	0.00083	CcSEcCtD
Danazol—Asthenia—Dexamethasone—multiple sclerosis	3.28e-05	0.000819	CcSEcCtD
Danazol—Asthenia—Betamethasone—multiple sclerosis	3.28e-05	0.000819	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—multiple sclerosis	3.25e-05	0.000814	CcSEcCtD
Danazol—Nausea—Prednisolone—multiple sclerosis	3.25e-05	0.000813	CcSEcCtD
Danazol—Pruritus—Dexamethasone—multiple sclerosis	3.23e-05	0.000808	CcSEcCtD
Danazol—Pruritus—Betamethasone—multiple sclerosis	3.23e-05	0.000808	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—multiple sclerosis	3.21e-05	0.000803	CcSEcCtD
Danazol—Vomiting—Triamcinolone—multiple sclerosis	3.2e-05	0.0008	CcSEcCtD
Danazol—Vomiting—Methylprednisolone—multiple sclerosis	3.19e-05	0.000798	CcSEcCtD
Danazol—Rash—Triamcinolone—multiple sclerosis	3.17e-05	0.000793	CcSEcCtD
Danazol—Dermatitis—Triamcinolone—multiple sclerosis	3.17e-05	0.000793	CcSEcCtD
Danazol—Rash—Methylprednisolone—multiple sclerosis	3.17e-05	0.000792	CcSEcCtD
Danazol—Dermatitis—Methylprednisolone—multiple sclerosis	3.16e-05	0.000791	CcSEcCtD
Danazol—Urticaria—Prednisone—multiple sclerosis	3.16e-05	0.00079	CcSEcCtD
Danazol—Headache—Triamcinolone—multiple sclerosis	3.15e-05	0.000788	CcSEcCtD
Danazol—Headache—Methylprednisolone—multiple sclerosis	3.15e-05	0.000787	CcSEcCtD
Danazol—Body temperature increased—Prednisone—multiple sclerosis	3.14e-05	0.000786	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.03e-05	0.000757	CcSEcCtD
Danazol—Dizziness—Dexamethasone—multiple sclerosis	3.02e-05	0.000755	CcSEcCtD
Danazol—Dizziness—Betamethasone—multiple sclerosis	3.02e-05	0.000755	CcSEcCtD
Danazol—CCL2—Fluorometholone—Methylprednisolone—multiple sclerosis	3.02e-05	0.0148	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Methylprednisolone—multiple sclerosis	3e-05	0.0148	CbGdCrCtD
Danazol—Nausea—Triamcinolone—multiple sclerosis	2.99e-05	0.000747	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—multiple sclerosis	2.98e-05	0.000746	CcSEcCtD
Danazol—Nausea—Methylprednisolone—multiple sclerosis	2.98e-05	0.000746	CcSEcCtD
Danazol—CCL2—Fluorometholone—Betamethasone—multiple sclerosis	2.97e-05	0.0146	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Dexamethasone—multiple sclerosis	2.97e-05	0.0146	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Dexamethasone—multiple sclerosis	2.95e-05	0.0145	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—multiple sclerosis	2.95e-05	0.0145	CbGdCrCtD
Danazol—Dyspepsia—Methotrexate—multiple sclerosis	2.93e-05	0.000731	CcSEcCtD
Danazol—Vomiting—Dexamethasone—multiple sclerosis	2.9e-05	0.000726	CcSEcCtD
Danazol—Vomiting—Betamethasone—multiple sclerosis	2.9e-05	0.000726	CcSEcCtD
Danazol—CCL2—Fluorometholone—Triamcinolone—multiple sclerosis	2.9e-05	0.0143	CbGdCrCtD
Danazol—Rash—Dexamethasone—multiple sclerosis	2.88e-05	0.00072	CcSEcCtD
Danazol—Rash—Betamethasone—multiple sclerosis	2.88e-05	0.00072	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—multiple sclerosis	2.88e-05	0.000719	CcSEcCtD
Danazol—Dermatitis—Betamethasone—multiple sclerosis	2.88e-05	0.000719	CcSEcCtD
Danazol—Fatigue—Methotrexate—multiple sclerosis	2.87e-05	0.000716	CcSEcCtD
Danazol—Headache—Betamethasone—multiple sclerosis	2.86e-05	0.000715	CcSEcCtD
Danazol—Headache—Dexamethasone—multiple sclerosis	2.86e-05	0.000715	CcSEcCtD
Danazol—Asthenia—Prednisone—multiple sclerosis	2.85e-05	0.000713	CcSEcCtD
Danazol—Pruritus—Prednisone—multiple sclerosis	2.81e-05	0.000703	CcSEcCtD
Danazol—CCL2—Fluorometholone—Prednisone—multiple sclerosis	2.75e-05	0.0135	CbGdCrCtD
Danazol—Nausea—Dexamethasone—multiple sclerosis	2.71e-05	0.000678	CcSEcCtD
Danazol—Nausea—Betamethasone—multiple sclerosis	2.71e-05	0.000678	CcSEcCtD
Danazol—CCL2—Fluorometholone—Prednisolone—multiple sclerosis	2.69e-05	0.0132	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—multiple sclerosis	2.67e-05	0.0131	CbGdCrCtD
Danazol—Urticaria—Methotrexate—multiple sclerosis	2.64e-05	0.00066	CcSEcCtD
Danazol—Dizziness—Prednisone—multiple sclerosis	2.63e-05	0.000658	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—multiple sclerosis	2.63e-05	0.000657	CcSEcCtD
Danazol—CCL2—Clobetasol propionate—Methylprednisolone—multiple sclerosis	2.55e-05	0.0126	CbGdCrCtD
Danazol—Vomiting—Prednisone—multiple sclerosis	2.53e-05	0.000632	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	2.53e-05	0.000735	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PTGER4—multiple sclerosis	2.52e-05	0.000733	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Methylprednisolone—multiple sclerosis	2.52e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—multiple sclerosis	2.51e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Betamethasone—multiple sclerosis	2.51e-05	0.0124	CbGdCrCtD
Danazol—Rash—Prednisone—multiple sclerosis	2.51e-05	0.000627	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—RGS1—multiple sclerosis	2.51e-05	0.000729	CbGpPWpGaD
Danazol—Dermatitis—Prednisone—multiple sclerosis	2.5e-05	0.000626	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.5e-05	0.000727	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	2.5e-05	0.000726	CbGpPWpGaD
Danazol—CCL2—Triamcinolone—Methylprednisolone—multiple sclerosis	2.49e-05	0.0123	CbGdCrCtD
Danazol—AR—Gene Expression—U2AF2—multiple sclerosis	2.49e-05	0.000724	CbGpPWpGaD
Danazol—AR—Gene Expression—HNRNPA1—multiple sclerosis	2.49e-05	0.000724	CbGpPWpGaD
Danazol—Headache—Prednisone—multiple sclerosis	2.49e-05	0.000623	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.49e-05	0.000723	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Betamethasone—multiple sclerosis	2.48e-05	0.0122	CbGdCrCtD
Danazol—CCL2—Flunisolide—Dexamethasone—multiple sclerosis	2.48e-05	0.0122	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—multiple sclerosis	2.45e-05	0.0121	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—multiple sclerosis	2.45e-05	0.0121	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—multiple sclerosis	2.45e-05	0.0121	CbGdCrCtD
Danazol—PGR—Signaling Pathways—LINGO1—multiple sclerosis	2.45e-05	0.000713	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCR3—multiple sclerosis	2.44e-05	0.000708	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	2.43e-05	0.012	CbGdCrCtD
Danazol—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	2.43e-05	0.000706	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Triamcinolone—multiple sclerosis	2.42e-05	0.0119	CbGdCrCtD
Danazol—GNRHR—GPCR downstream signaling—CNR1—multiple sclerosis	2.41e-05	0.0007	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—multiple sclerosis	2.39e-05	0.0118	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	2.39e-05	0.0118	CbGdCrCtD
Danazol—CCL2—Signaling by GPCR—CNR1—multiple sclerosis	2.39e-05	0.000695	CbGpPWpGaD
Danazol—Asthenia—Methotrexate—multiple sclerosis	2.38e-05	0.000596	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCR1—multiple sclerosis	2.38e-05	0.000691	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL13—multiple sclerosis	2.38e-05	0.000691	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GPR65—multiple sclerosis	2.38e-05	0.000691	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCR2—multiple sclerosis	2.37e-05	0.000689	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Methylprednisolone—multiple sclerosis	2.37e-05	0.0116	CbGdCrCtD
Danazol—Nausea—Prednisone—multiple sclerosis	2.36e-05	0.000591	CcSEcCtD
Danazol—Pruritus—Methotrexate—multiple sclerosis	2.35e-05	0.000588	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	2.34e-05	0.0115	CbGdCrCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.33e-05	0.000678	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Betamethasone—multiple sclerosis	2.33e-05	0.0115	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—multiple sclerosis	2.33e-05	0.0115	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—multiple sclerosis	2.33e-05	0.0115	CbGdCrCtD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	2.33e-05	0.000676	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—POMC—multiple sclerosis	2.33e-05	0.000676	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Prednisone—multiple sclerosis	2.3e-05	0.0113	CbGdCrCtD
Danazol—CCL2—Diflorasone—Methylprednisolone—multiple sclerosis	2.3e-05	0.0113	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Triamcinolone—multiple sclerosis	2.28e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—multiple sclerosis	2.28e-05	0.0112	CbGdCrCtD
Danazol—GNRHR—GPCR ligand binding—CCL2—multiple sclerosis	2.28e-05	0.000662	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Prednisolone—multiple sclerosis	2.27e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Diflorasone—Dexamethasone—multiple sclerosis	2.26e-05	0.0111	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—multiple sclerosis	2.26e-05	0.0111	CbGdCrCtD
Danazol—AR—Generic Transcription Pathway—PGR—multiple sclerosis	2.25e-05	0.000655	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Prednisolone—multiple sclerosis	2.24e-05	0.011	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—multiple sclerosis	2.22e-05	0.0109	CbGdCrCtD
Danazol—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	2.22e-05	0.000644	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	2.21e-05	0.000643	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Triamcinolone—multiple sclerosis	2.21e-05	0.0109	CbGdCrCtD
Danazol—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	2.21e-05	0.000641	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SRM—multiple sclerosis	2.2e-05	0.00064	CbGpPWpGaD
Danazol—Dizziness—Methotrexate—multiple sclerosis	2.2e-05	0.000549	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CNR1—multiple sclerosis	2.19e-05	0.000636	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR1—multiple sclerosis	2.17e-05	0.000632	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL13—multiple sclerosis	2.17e-05	0.000632	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL10—multiple sclerosis	2.17e-05	0.000631	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	2.17e-05	0.00063	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	2.17e-05	0.00063	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Prednisone—multiple sclerosis	2.16e-05	0.0106	CbGdCrCtD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.16e-05	0.000628	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL10—multiple sclerosis	2.15e-05	0.000626	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.13e-05	0.000619	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TAGAP—multiple sclerosis	2.13e-05	0.000618	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	2.12e-05	0.000616	CbGpPWpGaD
Danazol—Testosterone—ALB—multiple sclerosis	2.11e-05	0.0156	CrCbGaD
Danazol—Vomiting—Methotrexate—multiple sclerosis	2.11e-05	0.000528	CcSEcCtD
Danazol—CCL2—Desoximetasone—Prednisolone—multiple sclerosis	2.11e-05	0.0104	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisone—multiple sclerosis	2.1e-05	0.0103	CbGdCrCtD
Danazol—Rash—Methotrexate—multiple sclerosis	2.1e-05	0.000524	CcSEcCtD
Danazol—Dermatitis—Methotrexate—multiple sclerosis	2.09e-05	0.000523	CcSEcCtD
Danazol—Headache—Methotrexate—multiple sclerosis	2.08e-05	0.000521	CcSEcCtD
Danazol—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	2.07e-05	0.000601	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Prednisolone—multiple sclerosis	2.05e-05	0.0101	CbGdCrCtD
Danazol—CYP19A1—Biological oxidations—POMC—multiple sclerosis	2.04e-05	0.000593	CbGpPWpGaD
Danazol—CCL2—Budesonide—Methylprednisolone—multiple sclerosis	2.02e-05	0.00991	CbGdCrCtD
Danazol—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	2e-05	0.000583	CbGpPWpGaD
Danazol—PGR—Gene Expression—PABPC1—multiple sclerosis	2e-05	0.000583	CbGpPWpGaD
Danazol—CCL2—Budesonide—Betamethasone—multiple sclerosis	1.98e-05	0.00975	CbGdCrCtD
Danazol—CCL2—Budesonide—Dexamethasone—multiple sclerosis	1.98e-05	0.00975	CbGdCrCtD
Danazol—Nausea—Methotrexate—multiple sclerosis	1.97e-05	0.000494	CcSEcCtD
Danazol—AR—Gene Expression—ZFP36L1—multiple sclerosis	1.97e-05	0.000573	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL10—multiple sclerosis	1.97e-05	0.000573	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	1.94e-05	0.000564	CbGpPWpGaD
Danazol—CCL2—Budesonide—Triamcinolone—multiple sclerosis	1.94e-05	0.00953	CbGdCrCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.93e-05	0.00056	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	1.92e-05	0.000558	CbGpPWpGaD
Danazol—ESR1—Gene Expression—U2AF2—multiple sclerosis	1.92e-05	0.000558	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.9e-05	0.000553	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CCL5—multiple sclerosis	1.87e-05	0.000543	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	1.87e-05	0.000543	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—S1PR1—multiple sclerosis	1.86e-05	0.00054	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCL5—multiple sclerosis	1.85e-05	0.000539	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisone—multiple sclerosis	1.84e-05	0.00904	CbGdCrCtD
Danazol—PGR—Gene Expression—RPL5—multiple sclerosis	1.81e-05	0.000526	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GPC5—multiple sclerosis	1.81e-05	0.000526	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisolone—multiple sclerosis	1.8e-05	0.00883	CbGdCrCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.79e-05	0.000521	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	1.79e-05	0.00052	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—POMC—multiple sclerosis	1.79e-05	0.00052	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	1.73e-05	0.000504	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL5—multiple sclerosis	1.69e-05	0.000493	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCL3—multiple sclerosis	1.69e-05	0.000492	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CCR5—multiple sclerosis	1.68e-05	0.000489	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCR5—multiple sclerosis	1.67e-05	0.000485	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2RA—multiple sclerosis	1.66e-05	0.000482	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2RA—multiple sclerosis	1.65e-05	0.000478	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTGER4—multiple sclerosis	1.63e-05	0.000474	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	1.63e-05	0.000473	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PGR—multiple sclerosis	1.6e-05	0.000467	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RGS1—multiple sclerosis	1.58e-05	0.000459	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—VDR—multiple sclerosis	1.57e-05	0.000458	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCR3—multiple sclerosis	1.57e-05	0.000458	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CD28—multiple sclerosis	1.56e-05	0.000453	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	1.55e-05	0.000451	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	1.55e-05	0.000451	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL3—multiple sclerosis	1.55e-05	0.00045	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR2—multiple sclerosis	1.53e-05	0.000445	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCR5—multiple sclerosis	1.53e-05	0.000444	CbGpPWpGaD
Danazol—AR—Gene Expression—PABPC1—multiple sclerosis	1.53e-05	0.000444	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.52e-05	0.000442	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	1.52e-05	0.000441	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.51e-05	0.00044	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2RA—multiple sclerosis	1.5e-05	0.000438	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.5e-05	0.000436	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.49e-05	0.000434	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTGER4—multiple sclerosis	1.49e-05	0.000433	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.49e-05	0.000432	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PGR—multiple sclerosis	1.47e-05	0.000427	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	1.44e-05	0.000418	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCR3—multiple sclerosis	1.44e-05	0.000418	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CD28—multiple sclerosis	1.43e-05	0.000415	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPC5—multiple sclerosis	1.42e-05	0.000412	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CNR1—multiple sclerosis	1.41e-05	0.000411	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR2—multiple sclerosis	1.4e-05	0.000407	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.38e-05	0.000402	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.38e-05	0.000401	CbGpPWpGaD
Danazol—AR—Gene Expression—RPL5—multiple sclerosis	1.38e-05	0.0004	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR1—multiple sclerosis	1.37e-05	0.000398	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL13—multiple sclerosis	1.37e-05	0.000398	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—POMC—multiple sclerosis	1.31e-05	0.000382	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.31e-05	0.00038	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—POMC—multiple sclerosis	1.3e-05	0.000379	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CNR1—multiple sclerosis	1.29e-05	0.000376	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.28e-05	0.000372	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL10—multiple sclerosis	1.27e-05	0.00037	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.26e-05	0.000366	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.26e-05	0.000365	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	1.25e-05	0.000363	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Methylprednisolone—multiple sclerosis	1.23e-05	0.00606	CbGdCrCtD
Danazol—CCL2—Betamethasone—Methylprednisolone—multiple sclerosis	1.23e-05	0.00606	CbGdCrCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.23e-05	0.000358	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Betamethasone—multiple sclerosis	1.21e-05	0.00597	CbGdCrCtD
Danazol—CCL2—Betamethasone—Dexamethasone—multiple sclerosis	1.21e-05	0.00597	CbGdCrCtD
Danazol—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	1.21e-05	0.000353	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—POMC—multiple sclerosis	1.19e-05	0.000347	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Triamcinolone—multiple sclerosis	1.19e-05	0.00583	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Triamcinolone—multiple sclerosis	1.19e-05	0.00583	CbGdCrCtD
Danazol—ESR1—Gene Expression—PABPC1—multiple sclerosis	1.18e-05	0.000342	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.000341	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.17e-05	0.000341	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.17e-05	0.00034	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL2—multiple sclerosis	1.17e-05	0.00034	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL10—multiple sclerosis	1.16e-05	0.000338	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—TYK2—multiple sclerosis	1.16e-05	0.000337	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.15e-05	0.000333	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	1.14e-05	0.000331	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Prednisone—multiple sclerosis	1.12e-05	0.00553	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisone—multiple sclerosis	1.12e-05	0.00553	CbGdCrCtD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.12e-05	0.000326	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.11e-05	0.000324	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CD86—multiple sclerosis	1.11e-05	0.000323	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Prednisolone—multiple sclerosis	1.1e-05	0.0054	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisolone—multiple sclerosis	1.1e-05	0.0054	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—CCL5—multiple sclerosis	1.09e-05	0.000318	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	1.09e-05	0.000317	CbGpPWpGaD
Danazol—AR—Gene Expression—PGR—multiple sclerosis	1.08e-05	0.000315	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL5—multiple sclerosis	1.06e-05	0.000309	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GPC5—multiple sclerosis	1.06e-05	0.000308	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—TYK2—multiple sclerosis	1.06e-05	0.000308	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CD86—multiple sclerosis	1.02e-05	0.000296	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SPP1—multiple sclerosis	1.01e-05	0.000295	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL5—multiple sclerosis	1e-05	0.000291	CbGpPWpGaD
Danazol—PGR—Gene Expression—VDR—multiple sclerosis	9.94e-06	0.000289	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR5—multiple sclerosis	9.86e-06	0.000287	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL3—multiple sclerosis	9.76e-06	0.000284	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2RA—multiple sclerosis	9.72e-06	0.000283	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—multiple sclerosis	9.72e-06	0.000283	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.7e-06	0.000282	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.68e-06	0.000281	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—multiple sclerosis	9.65e-06	0.000281	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.49e-06	0.000276	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTGER4—multiple sclerosis	9.4e-06	0.000273	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RGS1—multiple sclerosis	9.27e-06	0.00027	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SPP1—multiple sclerosis	9.27e-06	0.00027	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.11e-06	0.000265	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCR3—multiple sclerosis	9.07e-06	0.000264	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.04e-06	0.000263	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR5—multiple sclerosis	9.02e-06	0.000262	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CD28—multiple sclerosis	8.99e-06	0.000261	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—multiple sclerosis	8.97e-06	0.000261	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2RA—multiple sclerosis	8.89e-06	0.000259	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR2—multiple sclerosis	8.83e-06	0.000257	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—multiple sclerosis	8.82e-06	0.000257	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GPR65—multiple sclerosis	8.79e-06	0.000256	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	8.75e-06	0.000255	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PGR—multiple sclerosis	8.35e-06	0.000243	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	8.21e-06	0.000239	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—multiple sclerosis	8.21e-06	0.000239	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CNR1—multiple sclerosis	8.15e-06	0.000237	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CD80—multiple sclerosis	8.11e-06	0.000236	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR1—multiple sclerosis	8.04e-06	0.000234	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	8.04e-06	0.000234	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.83e-06	0.000228	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—multiple sclerosis	7.71e-06	0.000224	CbGpPWpGaD
Danazol—AR—Gene Expression—VDR—multiple sclerosis	7.58e-06	0.00022	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CD80—multiple sclerosis	7.42e-06	0.000216	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK1—multiple sclerosis	7.38e-06	0.000215	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL10—multiple sclerosis	7.33e-06	0.000213	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.14e-06	0.000207	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—multiple sclerosis	7.05e-06	0.000205	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—multiple sclerosis	6.9e-06	0.000201	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TYK2—multiple sclerosis	6.85e-06	0.000199	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK1—multiple sclerosis	6.75e-06	0.000196	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—BCHE—multiple sclerosis	6.74e-06	0.000196	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SRM—multiple sclerosis	6.42e-06	0.000187	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CD86—multiple sclerosis	6.41e-06	0.000187	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL5—multiple sclerosis	6.31e-06	0.000184	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TYK2—multiple sclerosis	6.26e-06	0.000182	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—multiple sclerosis	6.25e-06	0.000182	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.95e-06	0.000173	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SPP1—multiple sclerosis	5.85e-06	0.00017	CbGpPWpGaD
Danazol—ESR1—Gene Expression—VDR—multiple sclerosis	5.84e-06	0.00017	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL3—multiple sclerosis	5.73e-06	0.000167	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—multiple sclerosis	5.7e-06	0.000166	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—multiple sclerosis	5.69e-06	0.000165	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—multiple sclerosis	5.67e-06	0.000165	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2RA—multiple sclerosis	5.61e-06	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	5.51e-06	0.00016	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PGR—multiple sclerosis	5.43e-06	0.000158	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—multiple sclerosis	5.39e-06	0.000157	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	5.33e-06	0.000155	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD28—multiple sclerosis	5.28e-06	0.000153	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—multiple sclerosis	5.21e-06	0.000152	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—multiple sclerosis	5.19e-06	0.000151	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR2—multiple sclerosis	5.18e-06	0.000151	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—multiple sclerosis	5.18e-06	0.00015	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—multiple sclerosis	4.93e-06	0.000143	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	4.82e-06	0.00014	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—multiple sclerosis	4.8e-06	0.000139	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR1—multiple sclerosis	4.78e-06	0.000139	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CD80—multiple sclerosis	4.68e-06	0.000136	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.52e-06	0.000131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.52e-06	0.000131	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—multiple sclerosis	4.46e-06	0.00013	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—multiple sclerosis	4.45e-06	0.000129	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—multiple sclerosis	4.44e-06	0.000129	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—multiple sclerosis	4.39e-06	0.000128	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK1—multiple sclerosis	4.36e-06	0.000127	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—multiple sclerosis	4.35e-06	0.000126	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	4.3e-06	0.000125	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.14e-06	0.00012	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—multiple sclerosis	4.08e-06	0.000119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—multiple sclerosis	4.07e-06	0.000118	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—multiple sclerosis	4.06e-06	0.000118	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK1—multiple sclerosis	3.99e-06	0.000116	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—multiple sclerosis	3.95e-06	0.000115	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TYK2—multiple sclerosis	3.95e-06	0.000115	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD86—multiple sclerosis	3.76e-06	0.000109	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL5—multiple sclerosis	3.71e-06	0.000108	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—multiple sclerosis	3.49e-06	0.000101	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SPP1—multiple sclerosis	3.43e-06	9.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.43e-06	9.97e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—multiple sclerosis	3.35e-06	9.74e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—multiple sclerosis	3.34e-06	9.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	3.29e-06	9.57e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—multiple sclerosis	3.29e-06	9.56e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—multiple sclerosis	3.18e-06	9.24e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—multiple sclerosis	3.11e-06	9.05e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—multiple sclerosis	3.06e-06	8.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—multiple sclerosis	3.04e-06	8.83e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—multiple sclerosis	3.01e-06	8.76e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—multiple sclerosis	2.77e-06	8.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD80—multiple sclerosis	2.75e-06	7.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—multiple sclerosis	2.61e-06	7.59e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—multiple sclerosis	2.57e-06	7.47e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—multiple sclerosis	2.56e-06	7.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—multiple sclerosis	2.55e-06	7.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK1—multiple sclerosis	2.51e-06	7.31e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—multiple sclerosis	2.32e-06	6.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TYK2—multiple sclerosis	2.32e-06	6.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.97e-06	5.72e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—multiple sclerosis	1.93e-06	5.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.93e-06	5.61e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.83e-06	5.31e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—multiple sclerosis	1.62e-06	4.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—multiple sclerosis	1.51e-06	4.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	1.5e-06	4.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	1.48e-06	4.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—multiple sclerosis	1.18e-06	3.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—multiple sclerosis	1.13e-06	3.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—multiple sclerosis	1.02e-06	2.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—multiple sclerosis	9.27e-07	2.7e-05	CbGpPWpGaD
